These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12153739)

  • 1. Circulating ghrelin levels in basal conditions and during glucose tolerance test in acromegalic patients.
    Cappiello V; Ronchi C; Morpurgo PS; Epaminonda P; Arosio M; Beck-Peccoz P; Spada A
    Eur J Endocrinol; 2002 Aug; 147(2):189-94. PubMed ID: 12153739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lowered ghrelin levels in acromegaly—normalization after treatment].
    Kozakowski J; Rabijewski M; Zgliczyński W
    Endokrynol Pol; 2005; 56(6):862-70. PubMed ID: 16821203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ghrelin test for the assessment of GH status in successfully treated patients with acromegaly.
    Pekic S; Doknic M; Miljic D; Joksimovic M; Glodic J; Djurovic M; Dieguez C; Casanueva F; Popovic V
    Eur J Endocrinol; 2006 May; 154(5):659-66. PubMed ID: 16645012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ghrelin administration affects circulating pituitary and gastro-entero-pancreatic hormones in acromegaly.
    Arosio M; Ronchi CL; Gebbia C; Pizzinelli S; Conte D; Cappiello V; Epaminonda P; Cesana BM; Beck-Peccoz P; Peracchi M
    Eur J Endocrinol; 2004 Jan; 150(1):27-32. PubMed ID: 14713276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum leptin levels in patients with acromegaly before and after correction of hypersomatotropism by trans-sphenoidal surgery.
    Damjanović SS; Petakov MS; Raicević S; Micić D; Marinković J; Dieguez C; Casanueva FF; Popović V
    J Clin Endocrinol Metab; 2000 Jan; 85(1):147-54. PubMed ID: 10634378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum leptin and ghrelin levels in active and inactive acromegalic patients during an oral glucose tolerance test.
    Roemmler J; Otto B; Steffin B; Bidlingmaier M; Schopohl J
    Exp Clin Endocrinol Diabetes; 2009 Mar; 117(3):135-41. PubMed ID: 18561093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-body insulin sensitivity rather than body-mass-index determines fasting and post-glucose-load growth hormone concentrations.
    Anderwald CH; Tura A; Gessl A; Smajis S; Bieglmayer C; Marculescu R; Luger A; Pacini G; Krebs M
    PLoS One; 2014; 9(12):e115184. PubMed ID: 25517727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum ghrelin levels in acromegaly: effects of surgical and long-acting octreotide therapy.
    Freda PU; Reyes CM; Conwell IM; Sundeen RE; Wardlaw SL
    J Clin Endocrinol Metab; 2003 May; 88(5):2037-44. PubMed ID: 12727951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating adiponectin levels and cardiovascular risk factors in acromegalic patients.
    Ronchi CL; Corbetta S; Cappiello V; Morpurgo PS; Giavoli C; Beck-Peccoz P; Arosio M; Spada A
    Eur J Endocrinol; 2004 May; 150(5):663-9. PubMed ID: 15132722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of oral glucose on acylated and total ghrelin secretion in acromegalic patients.
    Isidro ML; Nemina R; Garcia-Buela J; Sangiao-Alvarellos S; Cordido F
    Neuro Endocrinol Lett; 2007 Oct; 28(5):596-603. PubMed ID: 17984943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral glucose load inhibits circulating ghrelin levels to the same extent in normal and obese children.
    Baldelli R; Bellone S; Castellino N; Petri A; Rapa A; Vivenza D; Bellone J; Broglio F; Ghigo E; Bona G
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):255-9. PubMed ID: 16487433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acylated ghrelin secretion is acutely suppressed by oral glucose load or insulin-induced hypoglycemia independently of basal growth hormone secretion in humans.
    Kim SW; Kim KW; Shin CS; Park DJ; Park KS; Cho BY; Lee HK; Kim SY
    Horm Res; 2007; 67(5):211-9. PubMed ID: 17114888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of growth hormone (GH) on ghrelin, leptin, and adiponectin in GH-deficient patients.
    Edén Engström B; Burman P; Holdstock C; Karlsson FA
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5193-8. PubMed ID: 14602749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic ghrelin levels in subjects with growth hormone deficiency are not modified by one year of growth hormone replacement therapy.
    Janssen JA; van der Toorn FM; Hofland LJ; van Koetsveld P; Broglio F; Ghigo E; Lamberts SW; Jan van der Lely A
    Eur J Endocrinol; 2001 Dec; 145(6):711-6. PubMed ID: 11720895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of disease activity in treated acromegalic patients using a sensitive GH assay: should we achieve strict normal GH levels for a biochemical cure?
    Costa AC; Rossi A; Martinelli CE; Machado HR; Moreira AC
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3142-7. PubMed ID: 12107214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perturbations in adiponectin, leptin and resistin levels in acromegaly: lack of correlation with insulin resistance.
    Silha JV; Krsek M; Hana V; Marek J; Jezkova J; Weiss V; Murphy LJ
    Clin Endocrinol (Oxf); 2003 Jun; 58(6):736-42. PubMed ID: 12780751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of pegvisomant on serum ghrelin and leptin levels in acromegalic patients.
    Roemmler J; Otto B; Arafat AM; Bidlingmaier M; Schopohl J
    Eur J Endocrinol; 2010 Nov; 163(5):727-34. PubMed ID: 20699383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central ghrelin production does not substantially contribute to systemic ghrelin concentrations: a study in two subjects with active acromegaly.
    van der Toorn FM; Janssen JA; de Herder WW; Broglio F; Ghigo E; van der Lely AJ
    Eur J Endocrinol; 2002 Aug; 147(2):195-9. PubMed ID: 12153740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia.
    Popovic V; Doknic M; Maric N; Pekic S; Damjanovic A; Miljic D; Popovic S; Miljic N; Djurovic M; Jasovic-Gasic M; Dieguez C; Casanueva FF
    Neuroendocrinology; 2007; 85(4):249-56. PubMed ID: 17570902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance and insulin secretion in non-diabetic acromegalic patients.
    Coculescu M; Niculescu D; Lichiardopol R; Purice M
    Exp Clin Endocrinol Diabetes; 2007 May; 115(5):308-16. PubMed ID: 17516294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.